Previous Article | Next Article 
Journal of Virology, November 2004, p. 12557-12565, Vol. 78, No. 22
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.22.12557-12565.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Generation of Synthetic Severe Acute Respiratory Syndrome Coronavirus Pseudoparticles: Implications for Assembly and Vaccine Production
Yue Huang,
Zhi-yong Yang,
Wing-pui Kong, and
Gary J. Nabel*
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
Received 4 March 2004/
Accepted 29 June 2004
The recently emerged severe acute respiratory syndrome coronavirus (SARS-CoV) contains four structural genes, two replicase-transcriptase open reading frames, and more than five potential genes of unknown function. Despite this relative simplicity, the molecular regulation of SARS-CoV replication and assembly is not understood. Here, we report that two viral genes, encoding the SARS-CoV membrane (M) and nucleocapsid (N) proteins, are necessary and sufficient for formation of virus-like particles. Expression vectors encoding these two proteins were synthesized by using preferred human codons. When M and N expression plasmids were cotransfected into human 293 renal epithelial cells, pseudoparticles formed readily. The addition of a third gene, encoding the spike (S) glycoprotein, facilitated budding of particles that contained a corona-like halo resembling SARS-CoV when examined by transmission electron microscopy, with a buoyant density characteristic of coronaviruses. Specific biochemical interactions of these proteins were also shown in vitro. The S, M, and N proteins of the SARS-CoV are, therefore, necessary and sufficient for pseudovirus assembly. These findings advance the understanding of the morphogenesis of SARS-CoV and enable the generation of safe, conformational mimetics of the SARS virus that may facilitate the development of vaccines and antiviral drugs.
* Corresponding author. Mailing address: Vaccine Research Center, NIAID, National Institutes of Health, Bldg. 40, Room 4502, MSC 3005, 40 Convent Dr., Bethesda, MD 20982-3005. Phone: (301) 496-1852. Fax: (301) 480-0274. E-mail:
gnabel{at}nih.gov.
Journal of Virology, November 2004, p. 12557-12565, Vol. 78, No. 22
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.22.12557-12565.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Siu, Y. L., Teoh, K. T., Lo, J., Chan, C. M., Kien, F., Escriou, N., Tsao, S. W., Nicholls, J. M., Altmeyer, R., Peiris, J. S. M., Bruzzone, R., Nal, B.
(2008). The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles. J. Virol.
82: 11318-11330
[Abstract]
[Full Text]
-
Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., Suzuki, H., Karamatsu, K., Yasutomi, Y., Shida, H., Kidokoro, M., Mizuno, K., Matsushima, K., Kohara, M.
(2008). Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV. J. Immunol.
181: 6337-6348
[Abstract]
[Full Text]
-
Pacciarini, F., Ghezzi, S., Canducci, F., Sims, A., Sampaolo, M., Ferioli, E., Clementi, M., Poli, G., Conaldi, P. G., Baric, R., Vicenzi, E.
(2008). Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein. J. Virol.
82: 5137-5144
[Abstract]
[Full Text]
-
Boscarino, J. A., Logan, H. L., Lacny, J. J., Gallagher, T. M.
(2008). Envelope Protein Palmitoylations Are Crucial for Murine Coronavirus Assembly. J. Virol.
82: 2989-2999
[Abstract]
[Full Text]
-
Vlasova, A. N., Zhang, X., Hasoksuz, M., Nagesha, H. S., Haynes, L. M., Fang, Y., Lu, S., Saif, L. J.
(2007). Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nucleoprotein. J. Virol.
81: 13365-13377
[Abstract]
[Full Text]
-
McBride, C. E., Li, J., Machamer, C. E.
(2007). The Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains a Novel Endoplasmic Reticulum Retrieval Signal That Binds COPI and Promotes Interaction with Membrane Protein. J. Virol.
81: 2418-2428
[Abstract]
[Full Text]
-
Kuo, L., Hurst, K. R., Masters, P. S.
(2007). Exceptional Flexibility in the Sequence Requirements for Coronavirus Small Envelope Protein Function. J. Virol.
81: 2249-2262
[Abstract]
[Full Text]
-
DeDiego, M. L., Alvarez, E., Almazan, F., Rejas, M. T., Lamirande, E., Roberts, A., Shieh, W.-J., Zaki, S. R., Subbarao, K., Enjuanes, L.
(2007). A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo. J. Virol.
81: 1701-1713
[Abstract]
[Full Text]
-
Schaecher, S. R., Mackenzie, J. M., Pekosz, A.
(2007). The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles. J. Virol.
81: 718-731
[Abstract]
[Full Text]
-
Huang, C., Ito, N., Tseng, C.-T. K., Makino, S.
(2006). Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein.. J. Virol.
80: 7287-7294
[Abstract]
[Full Text]
-
Oostra, M., de Haan, C. A. M., de Groot, R. J., Rottier, P. J. M.
(2006). Glycosylation of the Severe Acute Respiratory Syndrome Coronavirus Triple-Spanning Membrane Proteins 3a and M. J. Virol.
80: 2326-2336
[Abstract]
[Full Text]
-
Huang, C., Narayanan, K., Ito, N., Peters, C. J., Makino, S.
(2006). Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is Released in Membranous Structures from 3a Protein-Expressing Cells and Infected Cells. J. Virol.
80: 210-217
[Abstract]
[Full Text]
-
Hurst, K. R., Kuo, L., Koetzner, C. A., Ye, R., Hsue, B., Masters, P. S.
(2005). A Major Determinant for Membrane Protein Interaction Localizes to the Carboxy-Terminal Domain of the Mouse Coronavirus Nucleocapsid Protein. J. Virol.
79: 13285-13297
[Abstract]
[Full Text]